![Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression | Scientific Reports Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsrep33401/MediaObjects/41598_2016_Article_BFsrep33401_Fig1_HTML.jpg)
Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression | Scientific Reports
![Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors | ACS Chemical Neuroscience Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.0c00741/asset/images/medium/cn0c00741_0003.gif)
Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors | ACS Chemical Neuroscience
![Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents | PNAS Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents | PNAS](https://www.pnas.org/cms/10.1073/pnas.1916570117/asset/c03e80f7-e96c-4e06-ae36-52c2c4fe7006/assets/graphic/pnas.1916570117fig01.jpeg)
Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents | PNAS
![Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors | ACS Chemical Neuroscience Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.0c00741/asset/images/large/cn0c00741_0001.jpeg)
Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors | ACS Chemical Neuroscience
![Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism | American Journal of Psychiatry Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism | American Journal of Psychiatry](https://ajp.psychiatryonline.org/cms/10.1176/appi.ajp.2018.18020138/asset/images/medium/appi.ajp.2018.18020138f2.gif)
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism | American Journal of Psychiatry
![Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism | Molecular Psychiatry Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism | Molecular Psychiatry](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41380-019-0503-4/MediaObjects/41380_2019_503_Fig1_HTML.png)
Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism | Molecular Psychiatry
![Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System](https://www.frontiersin.org/files/Articles/856672/fphar-13-856672-HTML/image_m/fphar-13-856672-g001.jpg)
Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System
![Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling](https://www.science.org/cms/asset/35d59cc9-5e24-4990-b0eb-4fc248e3274c/9_ra117_f1.gif)
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
![Frontiers | The Role of the Kappa Opioid System in Comorbid Pain and Psychiatric Disorders: Function and Implications Frontiers | The Role of the Kappa Opioid System in Comorbid Pain and Psychiatric Disorders: Function and Implications](https://www.frontiersin.org/files/myhome%20article%20library/642493/642493_Thumb_400.jpg)
Frontiers | The Role of the Kappa Opioid System in Comorbid Pain and Psychiatric Disorders: Function and Implications
![Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders? | Neuropsychopharmacology Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders? | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnpp.2014.261/MediaObjects/41386_2015_Article_BFnpp2014261_Fig1_HTML.jpg)
Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders? | Neuropsychopharmacology
![Biomolecules | Free Full-Text | Ketamine Improves Desensitization of µ-Opioid Receptors Induced by Repeated Treatment with Fentanyl but Not with Morphine Biomolecules | Free Full-Text | Ketamine Improves Desensitization of µ-Opioid Receptors Induced by Repeated Treatment with Fentanyl but Not with Morphine](https://www.mdpi.com/biomolecules/biomolecules-12-00426/article_deploy/html/images/biomolecules-12-00426-g001.png)
Biomolecules | Free Full-Text | Ketamine Improves Desensitization of µ-Opioid Receptors Induced by Repeated Treatment with Fentanyl but Not with Morphine
![Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability - ScienceDirect Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006322322018546-gr1.jpg)
Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability - ScienceDirect
![The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - ScienceDirect The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006322319313794-gr1.jpg)